“…With different mechanisms of action, digoxin, sunitinib, chloroquine, cyclosporine A and silver nanoparticles are promising candidates for broad spectrum antivirals that could be used in a combined antiviral therapy. Drug repurposing is now facilitated by a number of resources (Pollastri and Campbell, 2011), such as pathogen target bioinformatics resources, public data repositories of screening data, structural biology resources and compound collections, such as the library of small molecules from the National Institutes of Health (http://www.nihclinicalcollection.com) (Ashbrook et al, 2016;Cao et al, 2015) or the Canadian DrugBank (https://www.drugbank. ca/), a large drug database commonly used by computational drug repositioning methods.…”